Searched for
HEALTHCARE INVESTMENT STRATEGIES
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...- MF Tracker: How Edelweiss Large Cap Fund logged positive returns in last 10 calendar yearsEdelweiss Large Cap Fund has achieved a remarkable decade of positive returns, never dipping into negative territory. This consistency is a...
- India at risk of AI blackout? Why Bernstein wants India to have its own DeepSeekBernstein has warned that India risks an "AI blackout" if it remains dependent on foreign AI models, urging the country to develop its own ...
- A Rs 3.5 crore SIP corpus may still leave you middle class, warns Bengaluru CA. She explains how to wisely invest money to increase wealthA Bengaluru CA highlights a common investment pitfall: focusing solely on a large corpus without accounting for inflation's impact on futur...
- Jio Platforms IPO likely by October-November; AI and ARPU growth in focus: Piyush PandeyReliance Industries' Jio Platforms IPO is anticipated by October-November, with strong investor interest expected due to a small fresh equi...
- Nestle, Uber among global business leaders to back faster electrification shiftOver 100 global companies, including Nestle and Uber, are urging governments to prioritize electrification in economic strategies. They arg...
- UnitedHealth’s $3 billion AI push has bots calling doctorsThe largest US health insurer plans to invest $3 billion in AI over 2026 and 2027. UnitedHealth executives say they’re seeing a 2-to-1 retu...
- AI boom heading for a dot-com-style bust? ‘Dean of Valuation’ Aswath Damodaran warns correction could be more painful than 2008Global finance expert Aswath Damodaran warns AI's massive infrastructure spending, funded by debt, poses a greater risk than the dot-com cr...
- Reliance seeks to build India's sovereign AI backbone; unveils Jio call agent and AI home platformReliance Industries is building India's sovereign AI backbone. The company is partnering with Google and Meta. New AI-powered applications ...
- Reliance AGM 2026 Key Takeaways: Jio IPO, AI, satellite connectivity, JioTeleFrame & more; 10 biggest announcements from Ambani's vision for the futureReliance AGM 2026 Key Takeaways: Reliance Industries unveiled ambitious plans at its AGM 2026, including the approval of Jio Platforms' IPO...
- L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...
- HealthQuad raises Rs 550 crore, eyes Rs 1,700 crore fundHealthQuad has secured Rs 550 crore for its third fund. The venture capital firm aims to raise Rs 1,700 crore to back early-growth companie...
- Financials in a sweet spot, defence remains a structural bet: Dharmesh KantFinancial stocks are set to lead a market rally through June and July. Experts see banks and financial institutions benefiting from strong ...
- Major boost to Meghalaya's infrastructure as Nitin Gadkari lays foundation stones of 6 National Highway projectsMeghalaya's infrastructure receives a major boost with Union Minister Nitin Gadkari inaugurating and laying foundation stones for six highw...
- Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...
- NSE Indices launch 11 new sectoral indices including Nifty Power and Nifty HospitalsNSE Indices has introduced 11 new sectoral benchmarks, taking its total sectoral index count to 34. The move aims to deepen sector-specific...
- Sudip Bandyopadhyay bets on pharma, metals and select cyclicals as geopolitical risks easeEasing West Asia tensions boost global markets, prompting investors to reassess opportunities. Market veteran Sudip Bandyopadhyay favors ph...
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautiousGlobal challenges are impacting Indian stocks. West Asian tensions and rising US inflation create headwinds. Tech sector shifts also affect...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- 'Time to cherry pick again': Porinju Veliyath says small and midcaps have bottomed & Thomas Cook is his latest buyPorinju Veliyath sees the correction in small and midcap stocks ending. He believes patient investors will find rewards. Thomas Cook India ...
Load More
